Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01440621Phase 3Completed
Phase 3, randomised, double-blind trial in cancer-related fatigue (CRF) comparing Modafinil with Placebo (2 arms). Primary endpoint: Reduction in Cancer Related Fatigue at 12 weeks. Started Aug 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01440621.